CIK 0001781983
- Non-accelerated filer
- Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-07 | KDev Investments AB 10% owner | Sale | −241,703 | $34.55 | $8.4M | 1,992,586 |
| 2020-04-13 | KDev Investments AB 10% owner | Sale | −210,548 | $31.25 | $6.6M | 2,234,289 |
| 2019-10-07 | KDev Investments AB 10% owner | Conversion | +1,600,559 | 2,444,837 | ||
| 2019-10-07 | KDev Investments AB 10% owner | Conversion · Series A Convertible Preferred Stock | −579,647 | 0 | ||
| 2019-10-07 | KDev Investments AB 10% owner | Conversion · Series B Convertible Preferred Stock | −590,445 | 0 | ||
| 2019-10-07 | KDev Investments AB 10% owner | Conversion · Series C Convertible Preferred Stock | −430,467 | 0 |
Page 1 of 1 · 6 trades